HEPHAISTOS-Pharma

French tech company | Builders Republic

About

Biotech company developing innate-immunity cancer immunotherapies — third-generation TLR4 agonists, led by ONCO-Boost, designed to turn myeloid-rich “cold” tumours into tumours that respond to immune checkpoint inhibitors.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Seed
Founded
2018
City
ORSAY
Region
IDF
Tracked rounds
1
Amount raised
10 M€

Operations

  • Seed · 2024

Investors